世界の移植治療薬市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Transplantation Therapeutics Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A11967 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、移植治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。移植治療薬の種類別市場規模（カルシニューリン阻害剤、抗増殖剤、コルチコステロイド、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・移植治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Novartis、GlaxoSmithKline、AbbVie、Pfizer、Astellas Pharma、Gilead Sciences、SBI Biotech、Sanofi、Takeda ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：カルシニューリン阻害剤、抗増殖剤、コルチコステロイド、その他 ・用途別分析2016年-2026年：病院薬局、小売薬局、オンライン薬局 ・移植治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・移植治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・移植治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・移植治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・移植治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Transplantation Therapeutics Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Transplantation Therapeutics Drugs size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Transplantation Therapeutics Drugs market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Transplantation Therapeutics Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Calcineurin Inhibitors
Anti-Proliferative Agents
Corticosteroids
Others

Market segment by Application, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by players, this report covers
Novartis
GlaxoSmithKline
AbbVie
Pfizer
Astellas Pharma
Gilead Sciences
SBI Biotech
Sanofi
Takeda

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Transplantation Therapeutics Drugs
1.2 Classification of Transplantation Therapeutics Drugs by Type
1.2.1 Overview: Global Transplantation Therapeutics Drugs Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Transplantation Therapeutics Drugs Revenue Market Share by Type in 2020
1.2.3 Calcineurin Inhibitors
1.2.4 Anti-Proliferative Agents
1.2.5 Corticosteroids
1.2.6 Others
1.3 Global Transplantation Therapeutics Drugs Market by Application
1.3.1 Overview: Global Transplantation Therapeutics Drugs Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Transplantation Therapeutics Drugs Market Size & Forecast
1.5 Global Transplantation Therapeutics Drugs Market Size and Forecast by Region
1.5.1 Global Transplantation Therapeutics Drugs Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Transplantation Therapeutics Drugs Market Size by Region, (2016-2021)
1.5.3 North America Transplantation Therapeutics Drugs Market Size and Prospect (2016-2026)
1.5.4 Europe Transplantation Therapeutics Drugs Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Transplantation Therapeutics Drugs Market Size and Prospect (2016-2026)
1.5.6 South America Transplantation Therapeutics Drugs Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Transplantation Therapeutics Drugs Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Transplantation Therapeutics Drugs Market Drivers
1.6.2 Transplantation Therapeutics Drugs Market Restraints
1.6.3 Transplantation Therapeutics Drugs Trends Analysis
2 Company Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Transplantation Therapeutics Drugs Product and Solutions
2.1.4 Novartis Transplantation Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Novartis Recent Developments and Future Plans
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Transplantation Therapeutics Drugs Product and Solutions
2.2.4 GlaxoSmithKline Transplantation Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 GlaxoSmithKline Recent Developments and Future Plans
2.3 AbbVie
2.3.1 AbbVie Details
2.3.2 AbbVie Major Business
2.3.3 AbbVie Transplantation Therapeutics Drugs Product and Solutions
2.3.4 AbbVie Transplantation Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 AbbVie Recent Developments and Future Plans
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Transplantation Therapeutics Drugs Product and Solutions
2.4.4 Pfizer Transplantation Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Pfizer Recent Developments and Future Plans
2.5 Astellas Pharma
2.5.1 Astellas Pharma Details
2.5.2 Astellas Pharma Major Business
2.5.3 Astellas Pharma Transplantation Therapeutics Drugs Product and Solutions
2.5.4 Astellas Pharma Transplantation Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Astellas Pharma Recent Developments and Future Plans
2.6 Gilead Sciences
2.6.1 Gilead Sciences Details
2.6.2 Gilead Sciences Major Business
2.6.3 Gilead Sciences Transplantation Therapeutics Drugs Product and Solutions
2.6.4 Gilead Sciences Transplantation Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Gilead Sciences Recent Developments and Future Plans
2.7 SBI Biotech
2.7.1 SBI Biotech Details
2.7.2 SBI Biotech Major Business
2.7.3 SBI Biotech Transplantation Therapeutics Drugs Product and Solutions
2.7.4 SBI Biotech Transplantation Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 SBI Biotech Recent Developments and Future Plans
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Transplantation Therapeutics Drugs Product and Solutions
2.8.4 Sanofi Transplantation Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Sanofi Recent Developments and Future Plans
2.9 Takeda
2.9.1 Takeda Details
2.9.2 Takeda Major Business
2.9.3 Takeda Transplantation Therapeutics Drugs Product and Solutions
2.9.4 Takeda Transplantation Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Takeda Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Transplantation Therapeutics Drugs Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Transplantation Therapeutics Drugs Players Market Share
3.2.2 Top 10 Transplantation Therapeutics Drugs Players Market Share
3.2.3 Market Competition Trend
3.3 Transplantation Therapeutics Drugs Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Transplantation Therapeutics Drugs Revenue and Market Share by Type (2016-2021)
4.2 Global Transplantation Therapeutics Drugs Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Transplantation Therapeutics Drugs Revenue Market Share by Application (2016-2021)
5.2 Transplantation Therapeutics Drugs Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Transplantation Therapeutics Drugs Revenue by Type (2016-2026)
6.2 North America Transplantation Therapeutics Drugs Revenue by Application (2016-2026)
6.3 North America Transplantation Therapeutics Drugs Market Size by Country
6.3.1 North America Transplantation Therapeutics Drugs Revenue by Country (2016-2026)
6.3.2 United States Transplantation Therapeutics Drugs Market Size and Forecast (2016-2026)
6.3.3 Canada Transplantation Therapeutics Drugs Market Size and Forecast (2016-2026)
6.3.4 Mexico Transplantation Therapeutics Drugs Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Transplantation Therapeutics Drugs Revenue by Type (2016-2026)
7.2 Europe Transplantation Therapeutics Drugs Revenue by Application (2016-2026)
7.3 Europe Transplantation Therapeutics Drugs Market Size by Country
7.3.1 Europe Transplantation Therapeutics Drugs Revenue by Country (2016-2026)
7.3.2 Germany Transplantation Therapeutics Drugs Market Size and Forecast (2016-2026)
7.3.3 France Transplantation Therapeutics Drugs Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Transplantation Therapeutics Drugs Market Size and Forecast (2016-2026)
7.3.5 Russia Transplantation Therapeutics Drugs Market Size and Forecast (2016-2026)
7.3.6 Italy Transplantation Therapeutics Drugs Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Transplantation Therapeutics Drugs Revenue by Type (2016-2026)
8.2 Asia-Pacific Transplantation Therapeutics Drugs Revenue by Application (2016-2026)
8.3 Asia-Pacific Transplantation Therapeutics Drugs Market Size by Region
8.3.1 Asia-Pacific Transplantation Therapeutics Drugs Revenue by Region (2016-2026)
8.3.2 China Transplantation Therapeutics Drugs Market Size and Forecast (2016-2026)
8.3.3 Japan Transplantation Therapeutics Drugs Market Size and Forecast (2016-2026)
8.3.4 South Korea Transplantation Therapeutics Drugs Market Size and Forecast (2016-2026)
8.3.5 India Transplantation Therapeutics Drugs Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Transplantation Therapeutics Drugs Market Size and Forecast (2016-2026)
8.3.7 Australia Transplantation Therapeutics Drugs Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Transplantation Therapeutics Drugs Revenue by Type (2016-2026)
9.2 South America Transplantation Therapeutics Drugs Revenue by Application (2016-2026)
9.3 South America Transplantation Therapeutics Drugs Market Size by Country
9.3.1 South America Transplantation Therapeutics Drugs Revenue by Country (2016-2026)
9.3.2 Brazil Transplantation Therapeutics Drugs Market Size and Forecast (2016-2026)
9.3.3 Argentina Transplantation Therapeutics Drugs Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Transplantation Therapeutics Drugs Revenue by Type (2016-2026)
10.2 Middle East & Africa Transplantation Therapeutics Drugs Revenue by Application (2016-2026)
10.3 Middle East & Africa Transplantation Therapeutics Drugs Market Size by Country
10.3.1 Middle East & Africa Transplantation Therapeutics Drugs Revenue by Country (2016-2026)
10.3.2 Turkey Transplantation Therapeutics Drugs Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Transplantation Therapeutics Drugs Market Size and Forecast (2016-2026)
10.3.4 UAE Transplantation Therapeutics Drugs Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Transplantation Therapeutics Drugs Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Transplantation Therapeutics Drugs Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Transplantation Therapeutics Drugs Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Transplantation Therapeutics Drugs Revenue (USD Million) by Region (2016-2021)
Table 5. Global Transplantation Therapeutics Drugs Revenue Market Share by Region (2021-2026)
Table 6. Novartis Corporate Information, Head Office, and Major Competitors
Table 7. Novartis Major Business
Table 8. Novartis Transplantation Therapeutics Drugs Product and Solutions
Table 9. Novartis Transplantation Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 11. GlaxoSmithKline Major Business
Table 12. GlaxoSmithKline Transplantation Therapeutics Drugs Product and Solutions
Table 13. GlaxoSmithKline Transplantation Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. AbbVie Corporate Information, Head Office, and Major Competitors
Table 15. AbbVie Major Business
Table 16. AbbVie Transplantation Therapeutics Drugs Product and Solutions
Table 17. AbbVie Transplantation Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Pfizer Corporate Information, Head Office, and Major Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Transplantation Therapeutics Drugs Product and Solutions
Table 21. Pfizer Transplantation Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Astellas Pharma Corporate Information, Head Office, and Major Competitors
Table 23. Astellas Pharma Major Business
Table 24. Astellas Pharma Transplantation Therapeutics Drugs Product and Solutions
Table 25. Astellas Pharma Transplantation Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Gilead Sciences Corporate Information, Head Office, and Major Competitors
Table 27. Gilead Sciences Major Business
Table 28. Gilead Sciences Transplantation Therapeutics Drugs Product and Solutions
Table 29. Gilead Sciences Transplantation Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. SBI Biotech Corporate Information, Head Office, and Major Competitors
Table 31. SBI Biotech Major Business
Table 32. SBI Biotech Transplantation Therapeutics Drugs Product and Solutions
Table 33. SBI Biotech Transplantation Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Sanofi Corporate Information, Head Office, and Major Competitors
Table 35. Sanofi Major Business
Table 36. Sanofi Transplantation Therapeutics Drugs Product and Solutions
Table 37. Sanofi Transplantation Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Takeda Corporate Information, Head Office, and Major Competitors
Table 39. Takeda Major Business
Table 40. Takeda Transplantation Therapeutics Drugs Product and Solutions
Table 41. Takeda Transplantation Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Global Transplantation Therapeutics Drugs Revenue (USD Million) by Players (2019-2021)
Table 43. Global Transplantation Therapeutics Drugs Revenue Share by Players (2019-2021)
Table 44. Breakdown of Transplantation Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Transplantation Therapeutics Drugs Players Head Office, Products and Services Provided
Table 46. Transplantation Therapeutics Drugs Mergers & Acquisitions in the Past Five Years
Table 47. Transplantation Therapeutics Drugs New Entrants and Expansion Plans
Table 48. Global Transplantation Therapeutics Drugs Revenue (USD Million) by Type (2016-2021)
Table 49. Global Transplantation Therapeutics Drugs Revenue Share by Type (2016-2021)
Table 50. Global Transplantation Therapeutics Drugs Revenue Forecast by Type (2021-2026)
Table 51. Global Transplantation Therapeutics Drugs Revenue by Application (2016-2021)
Table 52. Global Transplantation Therapeutics Drugs Revenue Forecast by Application (2021-2026)
Table 53. North America Transplantation Therapeutics Drugs Revenue by Type (2016-2021) & (USD Million)
Table 54. North America Transplantation Therapeutics Drugs Revenue by Type (2021-2026) & (USD Million)
Table 55. North America Transplantation Therapeutics Drugs Revenue by Application (2016-2021) & (USD Million)
Table 56. North America Transplantation Therapeutics Drugs Revenue by Application (2021-2026) & (USD Million)
Table 57. North America Transplantation Therapeutics Drugs Revenue by Country (2016-2021) & (USD Million)
Table 58. North America Transplantation Therapeutics Drugs Revenue by Country (2021-2026) & (USD Million)
Table 59. Europe Transplantation Therapeutics Drugs Revenue by Type (2016-2021) & (USD Million)
Table 60. Europe Transplantation Therapeutics Drugs Revenue by Type (2021-2026) & (USD Million)
Table 61. Europe Transplantation Therapeutics Drugs Revenue by Application (2016-2021) & (USD Million)
Table 62. Europe Transplantation Therapeutics Drugs Revenue by Application (2021-2026) & (USD Million)
Table 63. Europe Transplantation Therapeutics Drugs Revenue by Country (2016-2021) & (USD Million)
Table 64. Europe Transplantation Therapeutics Drugs Revenue by Country (2021-2026) & (USD Million)
Table 65. Asia-Pacific Transplantation Therapeutics Drugs Revenue by Type (2016-2021) & (USD Million)
Table 66. Asia-Pacific Transplantation Therapeutics Drugs Revenue by Type (2021-2026) & (USD Million)
Table 67. Asia-Pacific Transplantation Therapeutics Drugs Revenue by Application (2016-2021) & (USD Million)
Table 68. Asia-Pacific Transplantation Therapeutics Drugs Revenue by Application (2021-2026) & (USD Million)
Table 69. Asia-Pacific Transplantation Therapeutics Drugs Revenue by Region (2016-2021) & (USD Million)
Table 70. Asia-Pacific Transplantation Therapeutics Drugs Revenue by Region (2021-2026) & (USD Million)
Table 71. South America Transplantation Therapeutics Drugs Revenue by Type (2016-2021) & (USD Million)
Table 72. South America Transplantation Therapeutics Drugs Revenue by Type (2021-2026) & (USD Million)
Table 73. South America Transplantation Therapeutics Drugs Revenue by Application (2016-2021) & (USD Million)
Table 74. South America Transplantation Therapeutics Drugs Revenue by Application (2021-2026) & (USD Million)
Table 75. South America Transplantation Therapeutics Drugs Revenue by Country (2016-2021) & (USD Million)
Table 76. South America Transplantation Therapeutics Drugs Revenue by Country (2021-2026) & (USD Million)
Table 77. Middle East & Africa Transplantation Therapeutics Drugs Revenue by Type (2016-2021) & (USD Million)
Table 78. Middle East & Africa Transplantation Therapeutics Drugs Revenue by Type (2021-2026) & (USD Million)
Table 79. Middle East & Africa Transplantation Therapeutics Drugs Revenue by Application (2016-2021) & (USD Million)
Table 80. Middle East & Africa Transplantation Therapeutics Drugs Revenue by Application (2021-2026) & (USD Million)
Table 81. Middle East & Africa Transplantation Therapeutics Drugs Revenue by Country (2016-2021) & (USD Million)
Table 82. Middle East & Africa Transplantation Therapeutics Drugs Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Transplantation Therapeutics Drugs Picture
Figure 2. Global Transplantation Therapeutics Drugs Revenue Market Share by Type in 2020
Figure 3. Calcineurin Inhibitors
Figure 4. Anti-Proliferative Agents
Figure 5. Corticosteroids
Figure 6. Others
Figure 7. Transplantation Therapeutics Drugs Revenue Market Share by Application in 2020
Figure 8. Hospital Pharmacies Picture
Figure 9. Retail Pharmacies Picture
Figure 10. Online Pharmacies Picture
Figure 11. Global Transplantation Therapeutics Drugs Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Transplantation Therapeutics Drugs Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Transplantation Therapeutics Drugs Revenue Market Share by Region (2016-2026)
Figure 14. Global Transplantation Therapeutics Drugs Revenue Market Share by Region in 2020
Figure 15. North America Transplantation Therapeutics Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Transplantation Therapeutics Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Transplantation Therapeutics Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Transplantation Therapeutics Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Transplantation Therapeutics Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Transplantation Therapeutics Drugs Market Drivers
Figure 21. Transplantation Therapeutics Drugs Market Restraints
Figure 22. Transplantation Therapeutics Drugs Market Trends
Figure 23. Novartis Recent Developments and Future Plans
Figure 24. GlaxoSmithKline Recent Developments and Future Plans
Figure 25. AbbVie Recent Developments and Future Plans
Figure 26. Pfizer Recent Developments and Future Plans
Figure 27. Astellas Pharma Recent Developments and Future Plans
Figure 28. Gilead Sciences Recent Developments and Future Plans
Figure 29. SBI Biotech Recent Developments and Future Plans
Figure 30. Sanofi Recent Developments and Future Plans
Figure 31. Takeda Recent Developments and Future Plans
Figure 32. Global Transplantation Therapeutics Drugs Revenue Share by Players in 2020
Figure 33. Transplantation Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Transplantation Therapeutics Drugs Revenue Market Share in 2020
Figure 35. Global Top 10 Players Transplantation Therapeutics Drugs Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Transplantation Therapeutics Drugs Revenue Share by Type in 2020
Figure 38. Global Transplantation Therapeutics Drugs Market Share Forecast by Type (2021-2026)
Figure 39. Global Transplantation Therapeutics Drugs Revenue Share by Application in 2020
Figure 40. Global Transplantation Therapeutics Drugs Market Share Forecast by Application (2021-2026)
Figure 41. North America Transplantation Therapeutics Drugs Sales Market Share by Type (2016-2026)
Figure 42. North America Transplantation Therapeutics Drugs Sales Market Share by Application (2016-2026)
Figure 43. North America Transplantation Therapeutics Drugs Revenue Market Share by Country (2016-2026)
Figure 44. United States Transplantation Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Transplantation Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Transplantation Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Transplantation Therapeutics Drugs Sales Market Share by Type (2016-2026)
Figure 48. Europe Transplantation Therapeutics Drugs Sales Market Share by Application (2016-2026)
Figure 49. Europe Transplantation Therapeutics Drugs Revenue Market Share by Country (2016-2026)
Figure 50. Germany Transplantation Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Transplantation Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Transplantation Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Transplantation Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Transplantation Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Transplantation Therapeutics Drugs Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Transplantation Therapeutics Drugs Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Transplantation Therapeutics Drugs Revenue Market Share by Region (2016-2026)
Figure 58. China Transplantation Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Transplantation Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Transplantation Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Transplantation Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Transplantation Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Transplantation Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Transplantation Therapeutics Drugs Sales Market Share by Type (2016-2026)
Figure 65. South America Transplantation Therapeutics Drugs Sales Market Share by Application (2016-2026)
Figure 66. South America Transplantation Therapeutics Drugs Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Transplantation Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Transplantation Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Transplantation Therapeutics Drugs Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Transplantation Therapeutics Drugs Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Transplantation Therapeutics Drugs Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Transplantation Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Transplantation Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Transplantation Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source

---